Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
48.1M
-
Shares change
-
-1.63M
-
Total reported value, excl. options
-
$1.23B
-
Value change
-
-$40.3M
-
Number of buys
-
92
-
Number of sells
-
-90
-
Price
-
$25.51
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q3 2025
216 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q3 2025.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.1M shares
.
Largest 10 shareholders include Casdin Capital, LLC (6.71M shares), BlackRock, Inc. (5.6M shares), T. Rowe Price Investment Management, Inc. (4.07M shares), Invesco Ltd. (3.6M shares), VANGUARD GROUP INC (2.97M shares), STATE STREET CORP (1.46M shares), FRED ALGER MANAGEMENT, LLC (1.11M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.1M shares), FMR LLC (1.02M shares), and Rockefeller Capital Management L.P. (1.01M shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.